Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
OrbusNeich® Medical Company Ltd. and P&F Products & Features®, under the joint partnership OrbusNeich P&F, today announced that the TricValve®...
OrbusNeich and P+F today announced they have entered into an agreement for the exclusive distribution and manufacturing of a range of innovative...
OrbusNeich Medical K.K. of Tokyo Japan has announced that the Japan Ministry of Health, Labour, and Welfare (MHLW) has granted Shonin market approval ...
One-year results from the REDUCE trial reported at TCT 2017 OrbusNeich has reported results from the REDUCE trial today in the Late-Breaking Clinical ...
OrbusNeich has reported results from the REDUCE trial today in the Late-Breaking Clinical Trial session at the 29th annual Transcatheter...
New results from the HARMONEE Japan/US Registration Trial, reported by OrbusNeich today in the First Report Investigations session at the 29th annual ...
Program to include late-breaking presentation of REDUCE clinical trial Data on more than 5,000 patients to be presented OrbusNeich, a global company...
Announcement marks company's official entry into the US market OrbusNeich, a global company specializing in the provision of life-changing vascular...
Die Bekanntgabe markiert den offiziellen Eintritt des Unternehmens in den US-Markt OrbusNeich, ein weltweit agierendes Unternehmen, das auf die...
Cette annonce marque l'entrée officielle de l'entreprise sur le marché des États-Unis OrbusNeich, une entreprise mondiale spécialisée dans la...
El anuncio marca la entrada oficial de la compañía dentro del mercado de Estados Unidos OrbusNeich, una compañía global especializada en el...
Launch of Scoreflex™ NC responds to cardiologists' need for a non-compliant scoring balloon in more resistant lesions OrbusNeich, a global company...
Mit der Einführung des neuen Scoreflex™ NC reagiert OrbusNeich auf den gestiegenen Bedarf interventioneller Kardiologen an einem Non-Compliant...
Le lancement de Scoreflex™ NC répond au besoin des cardiologues avec un ballon de scoring non compliant pour les lésions les plus résistantes...
El lanzamiento de Scoreflex™ NC responde a la necesidad de los cardiólogos de un balón scoring no distensible para lesiones más resistentes...
COMBO Plus: A combination of traditional drug-eluting stent (DES) components with the addition of a unique biological therapy and enhanced...
-OrbusNeich presenta el COMBO Plus Dual Therapy Stent de nueva generación para la rendotelizacion activa COMBO Plus: Una combinación de los...
OrbusNeich, una compañía global especializada en el suministro de soluciones vasculares que cambian las vidas, ha expandido su cartera incluyendo...
Die Innovatoren des COMBO™ Stents präsentieren Katheter für die unteren Extremitäten und AV-Fisteln. OrbusNeich, ein globales, auf lebensverändernde...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.